Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mogamulizumab versus investigator's choice in previously treated adult T-cell leukemia-lymphoma
2011-005738-20Phase 2Completed
- Sponsor
- Kyowa Kirin
- Start
- Jun 2012
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of mogamulizumab in adult T-cell leukemia-lymphoma (ATLL) (2 arms), sponsored by Kyowa Kirin. Primary endpoint: Overall response rate. Started Jun 2012; status: completed.
02
Drugs
mogamulizumab
03
Conditions
adult T-cell leukemia-lymphoma (ATLL)
Beyond the preview
Go deeper on 2011-005738-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005738-20.